Market Overview

A Peek Into The Market Before The Trading Starts

Related CSCO
Benzinga's M&A Chatter for Thursday July 31, 2014
Jive Software Shares Spike Up Amid Rosenblatt Comments
Andreessen Makes $90M Cyber Security Bet (Fox Business)
Related ITMN
InterMune Leads The Pack
4 Biotech Stocks Worth A Look Ahead Of FDA Approvals
Time to Play China's Semi-Hot Real-Estate Market? (Fox Business)

Pre-open movers US stock futures are slightly higher this morning. Futures for the Dow Jones Industrial Average gained 2 points to 12,764.00 and S&P 500 index futures rose 0.40 points to 1,351.00. Nasdaq 100 futures gained 5 points to 2,617.50.

A Peek Into Global Markets European markets were mixed today. The STOXX Europe 600 Index rose 0.17%, London's FTSE 100 Index gained 0.41%, French CAC 40 index dropped 0.30% and German DAX 30 index surged 0.10%.

Asian markets ended mostly higher, with Japan's Nikkei Stock Average rising 1.11%, Chinese Shanghai Composite dropping 0.34% and Australia's S&P/ASX 200 rising 0.23%. Hong Kong's Hang Seng index surged 0.53% and India's Sensex gained 0.22%.

Broker Recommendation Analysts at BMO Capital upgraded Cisco Systems (NASDAQ: CSCO) from “market perform” to “outperform.” The target price for Cisco has been raised from $20 to $21.

Cisco shares dropped 0.06% to $17.17 in after-hours trading.

Breaking news

  • InterMune (NASDAQ: ITMN) today announced that on June 19, 2012, the company completed the previously announced sale of its rights to Actimmune® (interferon gamma-1b) to Vidara Therapeutics International Limited (Vidara). To read the full news, click here.
  • Acacia Research (NASDAQ: ACTG) announced today that a subsidiary has acquired patents for x-ray powder diffraction technology. To read the full news, click here.
  • Illumina (NASDAQ: ILMN) today launched the RapidTrack Whole Genome Sequencing Service (RapidTrack WGS), a new offering in its FastTrack Sequencing Services operation that delivers a whole human genome in less than two weeks. To read the full news, click here.
  • CB&I (NYSE: CBI) announced today that it has been awarded a contract valued in excess of US$40 million by Nizhnekamskneftekhim OAO (NKNK) to provide front end engineering and design (FEED) services for a new ethylene plant. To read the full news,

Posted-In: BMO Capital US Stock FuturesNews Futures Global Pre-Market Outlook Markets

 

Most Popular

Related Articles (ACTG + CBI)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters